Latest Posts

10 Apr 2019

SPRY HEALTH KEEPS TIGHT FOCUS WITH THE LOOP SYSTEM

  The Palo Alto, California-based company has received FDA clearance for a wearable that can remotely monitor patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD), allowing the detection of early signs of deterioration before symptoms are noticeable. Spry Health’s tight focus could have significantly beneficial implications for

0
10 Apr 2019

SVS JOURNAL: EVT IS THE NEW CASH COW FOR NON-VASCULAR DOCTORS; ETHICAL ISSUES RAISED

A new report suggests that providers who are not traditionally associated with the treatment of venous disease are driving the rapid increase in endovenous therapies. A compound annual growth rate of 15 percent has been observed for minimally-invasive procedures to treat superficial venous reflux over the past decade. In the

0
10 Apr 2019

LETHAL PLANS: When seniors turn to suicide in long-term care

      By Melissa Bailey and JoNel Aleccia When Larry Anders moved into the Bay at Burlington nursing home in late 2017, he wasn’t supposed to be there long. At 77, the stoic Wisconsin machinist had just endured the death of his wife of 51 years and a grim new diagnosis: throat

0
09 Apr 2019

AVLS to begin receiving research abstracts APRIL 17 for 2019 Annual Congress Emerging Science

The American Vein and Lymphatic Society (AVLS) will begin accepting research abstracts for presentation at the AVLS 2019 Annual Congress on April 17. Access to emerging science in the medical field is essential for physicians to deepen clinical competence and improve their practice. The AVLS 2019 Annual Congress Emerging Science

0
09 Apr 2019

 MERZ NORTH AMERICA REGAINS EXCLUSIVE DISTRIBUTION OF ASCLERA (POLIDOCANOL) INJECTION

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able

0
SHARE

Home